Correction to “Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation”

InfoMetricsFiguresRef. Journal of Medicinal ChemistryVol 67/Issue 16Article This publication is free to access through this site. Learn More CiteCitationCitation and abstractCitation and referencesMore citation options ShareShare onFacebookX (Twitter)WeChatLinkedInRedditEmailJump toExpandCollapse ORIGINAL ARTICLE This notice is a correctionAddition/CorrectionAugust 13, 2024Correction to "Design and Synthesis of Novel Cereblon Binders for Use in Targeted Protein Degradation"Click to copy article linkArticle link copied!Stephen Norris*Stephen NorrisMore by Stephen Norrishttps://orcid.org/0009-0009-7323-4629Xiaochu BaXiaochu BaMore by Xiaochu BaJayce RhodesJayce RhodesMore by Jayce RhodesDehua HuangDehua HuangMore by Dehua HuangGody KhambattaGody KhambattaMore by Gody Khambattahttps://orcid.org/0009-0008-9095-1892Jennifer BuenviajeJennifer BuenviajeMore by Jennifer BuenviajeSurendra NayakSurendra NayakMore by Surendra NayakJoseph MeiringJoseph MeiringMore by Joseph MeiringSamantha ReissSamantha ReissMore by Samantha ReissShuichan XuShuichan XuMore by Shuichan XuLihong ShiLihong ShiMore by Lihong Shihttps://orcid.org/0009-0002-1216-8014Brandon WhitefieldBrandon WhitefieldMore by Brandon WhitefieldMatt AlexanderMatt AlexanderMore by Matt AlexanderEvan J. HornEvan J. HornMore by Evan J. HornMatthew CorreaMatthew CorreaMore by Matthew CorreaLida TehraniLida TehraniMore by Lida TehraniJoshua D. HansenJoshua D. HansenMore by Joshua D. HansenPatrick PapaPatrick PapaMore by Patrick PapaDeborah S. MortensenDeborah S. MortensenMore by Deborah S. Mortensenhttps://orcid.org/0000-0002-9144-0962Jean-François BrazeauJean-François BrazeauMore by Jean-François BrazeauOpen PDFJournal of Medicinal ChemistryCite this: J. Med. Chem. 2024, 67, 16, 14692Click to copy citationCitation copied!https://pubs.acs.org/doi/10.1021/acs.jmedchem.4c01356https://doi.org/10.1021/acs.jmedchem.4c01356Published August 13, 2024 Publication History Received 26 July 2024Published online 13 August 2024Published in issue 22 August 2024correctionCopyright © 2024 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissionsThis publication is licensed for personal use by The American Chemical Society. ACS PublicationsCopyright © 2024 American Chemical SocietyAddition: The author list has been updated to include Jean-François Brazeau, Bristol Myers Squibb, San Diego, California 92121, United States.Addition: Specific references to patent litearture disclosures have been added (refs (2−11) here), where we had previously referenced only a review article of the patent literature. We have also added one reference from the scientific literature found during this reference update (ref (1) here), though this paper was likely under review at the time of our manuscript submission.p16388: While there have been several recent disclosures of similar nontraditional CRBN binders in the scientific (1) and patent (2−11) literature, these had not been disclosed at the time of the work described here.Author InformationClick to copy section linkSection link copied!Corresponding AuthorStephen Norris; https://orcid.org/0009-0009-7323-4629; Email: AuthorsXiaochu BaJayce RhodesDehua HuangGody Khambatta; https://orcid.org/0009-0008-9095-1892Jennifer BuenviajeSurendra NayakJoseph MeiringSamantha ReissShuichan XuLihong Shi; https://orcid.org/0009-0002-1216-8014Brandon WhitefieldMatt AlexanderEvan J. HornMatthew CorreaLida TehraniJoshua D. HansenPatrick PapaDeborah S. Mortensen; https://orcid.org/0000-0002-9144-0962Jean-François BrazeauReferencesClick to copy section linkSection link copied! This article references 11 other publications. 1Steinebach, C.; Bricelj, A.; Murgai, A.; Sosič, I.; Bischof, L.; Ng, Y. L. D.; Heim, C.; Maiwald, S.; Proj, M.; Voget, R.; Feller, F.; Košmrlj, J.; Sapozhnikova, V.; Schmidt, A.; Zuleeg, M. R.; Lemnitzer, P.; Mertins, P.; Hansen, F. K.; Gütschow, M.; Krönke, J.; Hartmann, M. D. Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs. J. Med. Chem. 2023, 66 (21), 14513– 14543, DOI: 10.1021/acs.jmedchem.3c00851 Google ScholarThere is no corresponding record for this reference.2Phillips, A. J.; Nasveschuk, C. G.; Henderson, J. A.; Liang, Y.; Chen, C.; Duplessis, M.; He, M.; Lazarski, K. Amine-linked C3-glutarimide degronimers for target protein degradation. WO2017197051A1, 2017.Google ScholarThere is no corresponding record for this reference.3Burnette, P.; Lawrence, N. J.; Lawrence, H.; Dimeric immuno-modulatory compounds against cereblon-based mechanisms. WO2020014489A2, 2020.Google ScholarThere is no corresponding record for this reference.4Ammirante, M.; Bahmanyar, S.; Correa, M. D.; Grant, V.; Hansen, J.; Horn, E. J.; Kercher, T. S.; Mayne, C.; Nagy; , Mark, A.; Narla, R. K.; Nayak, S.; Norris, S.; Papa, P.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Whitefield, B. W.; Xu, S. Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith. WO2020132016A1, 2020.Google ScholarThere is no corresponding record for this reference.5Phillips, A. J.; Nasveschuk, C. G.; Henderson, J. A.; Liang, Y.; He, M.; Duplessis, M.; Chen, C. N/O-linked degrons and degronimers for protein degradation. WO2018237026A1, 2018.Google ScholarThere is no corresponding record for this reference.6Phillips, A. J.; Nasveschuk, C. G.; Henderson, J. A.; Liang, Y.; He, M.; Lazarski, K.; Veits, G. K.; Vora, H. U. C3-carbon linked glutarimide degronimers for target protein degradation. WO2017197046A1, 2017.Google ScholarThere is no corresponding record for this reference.7Alexander, M. D.; Correa, M. D.; Dalvie, D.; Grant, V.; Hansen, J.; Harris, R. L.; Horn, E. J.; Huang, D.; Mayne, C.; Norris, S.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Tehrani, L.; Whitefield, B. W. Cereblon binding compounds, compositions thereof, and methods of treatment therewith. WO2021262812A1, 2021.Google ScholarThere is no corresponding record for this reference.8Alexander, M. D.; Correa, M. D.; Dalvie, D.; Grant, V.; Hansen, J.; Harris, R. L.; Horn, E. J.; Huang, D.; Mayne, C.; Norris, S.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Tehrani, L.; Whitefield, B. W. Cereblon binding compounds, compositions thereof, and methods of treatment therewith. WO2022272074A1, 2022.Google ScholarThere is no corresponding record for this reference.9Alexander, M. D.; Correa, M. D.; Dalvie, D.; Grant, V.; Hansen, J.; Harris, R. L.; Horn, E. J.; Huang, D.; Mayne, C.; Norris, S.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Tehrani, L.; Whitefield, B. W. Cereblon binding compounds, compositions thereof, and methods of treatment therewith. WO2021262815A1, 2021.Google ScholarThere is no corresponding record for this reference.10Huang, D.; Alexander, M. D.; Whitefield, B. W.; Shunatona, H. P.; Dodd, D. S.; Mortensen, D. S.; Miseo, G.; Holmberg-Douglas, N.; Rhodes, J.; Griffin, J. Heterocyclic compounds as modulators of BCL6 as ligand directed degraders. WO2023212147A1, 2023.Google ScholarThere is no corresponding record for this reference.11Mainolfi, N.; Ji, N.; Kluge, A. F. CRBN ligands and uses thereof. WO2019140387A1, 2019.Google ScholarThere is no corresponding record for this reference.Cited By Click to copy section linkSection link copied!This article has not yet been cited by other publications.Download PDFFiguresReferencesOpen PDF Get e-AlertsGet e-AlertsJournal of Medicinal ChemistryCite this: J. Med. Chem. 2024, 67, 16, 14692Click to copy citationCitation copied!https://doi.org/10.1021/acs.jmedchem.4c01356Published August 13, 2024 Publication History Received 26 July 2024Published online 13 August 2024Published in issue 22 August 2024Copyright © 2024 American Chemical Society. This publication is available under these Terms of Use. Request reuse permissionsArticle Views344Altmetric-Citations-Learn about these metrics closeArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.Recommended Articles FiguresReferencesThis publication has no figures.References This article references 11 other publications. 1Steinebach, C.; Bricelj, A.; Murgai, A.; Sosič, I.; Bischof, L.; Ng, Y. L. D.; Heim, C.; Maiwald, S.; Proj, M.; Voget, R.; Feller, F.; Košmrlj, J.; Sapozhnikova, V.; Schmidt, A.; Zuleeg, M. R.; Lemnitzer, P.; Mertins, P.; Hansen, F. K.; Gütschow, M.; Krönke, J.; Hartmann, M. D. Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs. J. Med. Chem. 2023, 66 (21), 14513– 14543, DOI: 10.1021/acs.jmedchem.3c00851 There is no corresponding record for this reference.2Phillips, A. J.; Nasveschuk, C. G.; Henderson, J. A.; Liang, Y.; Chen, C.; Duplessis, M.; He, M.; Lazarski, K. Amine-linked C3-glutarimide degronimers for target protein degradation. WO2017197051A1, 2017.There is no corresponding record for this reference.3Burnette, P.; Lawrence, N. J.; Lawrence, H.; Dimeric immuno-modulatory compounds against cereblon-based mechanisms. WO2020014489A2, 2020.There is no corresponding record for this reference.4Ammirante, M.; Bahmanyar, S.; Correa, M. D.; Grant, V.; Hansen, J.; Horn, E. J.; Kercher, T. S.; Mayne, C.; Nagy; , Mark, A.; Narla, R. K.; Nayak, S.; Norris, S.; Papa, P.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Whitefield, B. W.; Xu, S. Substituted 3-((3-aminophenyl)amino)piperidine-2,6-dione compounds, compositions thereof, and methods of treatment therewith. WO2020132016A1, 2020.There is no corresponding record for this reference.5Phillips, A. J.; Nasveschuk, C. G.; Henderson, J. A.; Liang, Y.; He, M.; Duplessis, M.; Chen, C. N/O-linked degrons and degronimers for protein degradation. WO2018237026A1, 2018.There is no corresponding record for this reference.6Phillips, A. J.; Nasveschuk, C. G.; Henderson, J. A.; Liang, Y.; He, M.; Lazarski, K.; Veits, G. K.; Vora, H. U. C3-carbon linked glutarimide degronimers for target protein degradation. WO2017197046A1, 2017.There is no corresponding record for this reference.7Alexander, M. D.; Correa, M. D.; Dalvie, D.; Grant, V.; Hansen, J.; Harris, R. L.; Horn, E. J.; Huang, D.; Mayne, C.; Norris, S.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Tehrani, L.; Whitefield, B. W. Cereblon binding compounds, compositions thereof, and methods of treatment therewith. WO2021262812A1, 2021.There is no corresponding record for this reference.8Alexander, M. D.; Correa, M. D.; Dalvie, D.; Grant, V.; Hansen, J.; Harris, R. L.; Horn, E. J.; Huang, D.; Mayne, C.; Norris, S.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Tehrani, L.; Whitefield, B. W. Cereblon binding compounds, compositions thereof, and methods of treatment therewith. WO2022272074A1, 2022.There is no corresponding record for this reference.9Alexander, M. D.; Correa, M. D.; Dalvie, D.; Grant, V.; Hansen, J.; Harris, R. L.; Horn, E. J.; Huang, D.; Mayne, C.; Norris, S.; Plantevin-Krenitsky, V.; Sapienza, J. J.; Tehrani, L.; Whitefield, B. W. Cereblon binding compounds, compositions thereof, and methods of treatment therewith. WO2021262815A1, 2021.There is no corresponding record for this reference.10Huang, D.; Alexander, M. D.; Whitefield, B. W.; Shunatona, H. P.; Dodd, D. S.; Mortensen, D. S.; Miseo, G.; Holmberg-Douglas, N.; Rhodes, J.; Griffin, J. Heterocyclic compounds as modulators of BCL6 as ligand directed degraders. WO2023212147A1, 2023.There is no corresponding record for this reference.11Mainolfi, N.; Ji, N.; Kluge, A. F. CRBN ligands and uses thereof. WO2019140387A1, 2019.There is no corresponding record for this reference.